Correlation Between Pfizer and IShares MSCI
Can any of the company-specific risk be diversified away by investing in both Pfizer and IShares MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and IShares MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and iShares MSCI USA, you can compare the effects of market volatilities on Pfizer and IShares MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of IShares MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and IShares MSCI.
Diversification Opportunities for Pfizer and IShares MSCI
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Pfizer and IShares is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and iShares MSCI USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares MSCI USA and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with IShares MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares MSCI USA has no effect on the direction of Pfizer i.e., Pfizer and IShares MSCI go up and down completely randomly.
Pair Corralation between Pfizer and IShares MSCI
Considering the 90-day investment horizon Pfizer Inc is expected to generate 1.18 times more return on investment than IShares MSCI. However, Pfizer is 1.18 times more volatile than iShares MSCI USA. It trades about 0.01 of its potential returns per unit of risk. iShares MSCI USA is currently generating about -0.08 per unit of risk. If you would invest 2,613 in Pfizer Inc on December 26, 2024 and sell it today you would earn a total of 1.00 from holding Pfizer Inc or generate 0.04% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. iShares MSCI USA
Performance |
Timeline |
Pfizer Inc |
iShares MSCI USA |
Pfizer and IShares MSCI Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and IShares MSCI
The main advantage of trading using opposite Pfizer and IShares MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, IShares MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares MSCI will offset losses from the drop in IShares MSCI's long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
IShares MSCI vs. iShares MSCI KLD | IShares MSCI vs. iShares ESG Aware | IShares MSCI vs. iShares MSCI ACWI | IShares MSCI vs. SPDR SSGA Gender |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data |